Showing results (921-930 of 1,061) with videos related to
Sort By:
Pageof 107
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
A peptide extension dictates IgM assemblyDzana Pasalic, Benedikt Weber, Chiara Giannone, et al.Journal of Clinical and Experimental Neuropsychology|August 10, 2010
Medication and finance management among HIV-infected adults: the impact of age and cognitionApril D Thames, Michelle S Kim, Brian W Becker, et al.International Journal of Cancer|August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacyT M Behr, S Memtsoudis, R M Sharkey, et al.Science (New York, N.Y.)|June 23, 2022
Global ocean lipidomes show a universal relationship between temperature and lipid unsaturationHenry C Holm, Helen F Fredricks, Shavonna M Bent, et al.Biochemistry|July 18, 2002
The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonatesErnest Asante-Appiah, Sangita Patel, Claude Dufresne, et al.Molecular Biology and Evolution|September 7, 2021
Altering the Binding Properties of PRDM9 Partially Restores Fertility across the Species BoundaryBenjamin Davies, Anjali Gupta Hinch, Alberto Cebrian-Serrano, et al.Nucleic Acids Research|April 9, 2001
An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expressionH Yue, P S Eastman, B B Wang, et al.The Journal of Biological Chemistry|January 13, 2006
Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphataseErnest Asante-Appiah, Sangita Patel, Caroline Desponts, et al.Physical Review Letters|September 26, 2012
Interference carpets in above-threshold ionization: from the Coulomb-free to the Coulomb-dominated regimePh A Korneev, S V Popruzhenko, S P Goreslavski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignanciesT M Behr, B Wörmann, M Gramatzki, et al.Pageof 107